, 1962) and probable therapeutic effects in individuals. The early clinical trials used largely LSD even though a lot of the the latest hallucinogen scientific tests applied psilocybin as a result of its simplicity of use a result of the shorter action and less controversial history (Nichols et al In https://thebookmarkplaza.com/story17699567/what-does-lsd-microdosing-benefits-and-risks-mean